IKONISYS SA (ALIKO.PA) Stock Price & Overview
EPA:ALIKO • FR00140048X2
Current stock price
The current stock price of ALIKO.PA is 1.41 EUR. Today ALIKO.PA is down by -0.7%. In the past month the price decreased by -5.05%. In the past year, price decreased by -11.87%.
ALIKO.PA Key Statistics
- Market Cap
- 22.334M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
ALIKO.PA Stock Performance
ALIKO.PA Stock Chart
ALIKO.PA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ALIKO.PA. When comparing the yearly performance of all stocks, ALIKO.PA is a bad performer in the overall market: 85.76% of all stocks are doing better.
ALIKO.PA Earnings
ALIKO.PA Forecast & Estimates
9 analysts have analysed ALIKO.PA and the average price target is 2.86 EUR. This implies a price increase of 102.55% is expected in the next year compared to the current price of 1.41.
ALIKO.PA Groups
Sector & Classification
ALIKO.PA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALIKO.PA Ownership
ALIKO.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.12 | 96.021B | ||
| 2M6 | MEDTRONIC PLC | 14.16 | 94.468B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.69 | 43.891B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.72 | 24.41B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.67 | 24.333B | ||
| BIM | BIOMERIEUX | 18.93 | 10.8B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.67 | 3.782B | ||
| DIA | DIASORIN SPA | 15.63 | 3.541B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.87 | 2.49B | ||
| DRW3 | DRAEGERWERK AG - PREF | 12.1 | 1.844B | ||
| DRW8 | DRAEGERWERK AG | 9.52 | 1.452B | ||
| ELN | EL.EN. SPA | 18.17 | 1.104B | ||
| EUZ | ECKERT & ZIEGLER SE | 19.36 | 990.277M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALIKO.PA
Company Profile
Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.
Company Info
IPO: 2021-07-19
IKONISYS SA
62 Rue De Caumartin, Paris 9
Paris ILE-DE-FRANCE FR
Employees: 15
IKONISYS SA / ALIKO.PA FAQ
What does IKONISYS SA do?
Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.
Can you provide the latest stock price for IKONISYS SA?
The current stock price of ALIKO.PA is 1.41 EUR. The price decreased by -0.7% in the last trading session.
Does IKONISYS SA pay dividends?
ALIKO.PA does not pay a dividend.
What is the ChartMill rating of IKONISYS SA stock?
ALIKO.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Would investing in IKONISYS SA be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALIKO.PA.